> Возможностей в Telegram + Портфель + Сделки + Обзоры
08.08.2025

💰Gilead Sciences: отчет за 2 квартал, опубликованный вчера на постмаркете

@usstocksnews | YouTube | VK Видео | Чат

• Revenue: $7.08B (est. $6.97B)
• Adj. EPS: $2.01 (est. $1.98)
• Product Sales: $28.30B–$28.70B (est. $28.45B)
• Veklury Revenue: $121M (est. $200.1M)
• Biktarvy Revenue: $3.53B (est. $3.37B)
• Trodelvy Revenue: $364M (est. $345.4M)

• Sees FY Adj. EPS: $7.95–$8.25 (saw $7.70–$8.10)
• Sees FY Veklury Revenue: ~$1.00B
• Raises Guidance On Robust Demand For HIV Treatments

#gild

Переходи в чат t.me/USstocksnews_chat